Resuscitative Endovascular Balloon Occlusion of the Aorta in Patients With Exsanguinating Hemorrhage

To the Editor The results of a recent randomized clinical trial demonstrated that the incorporation of REBOA into standard trauma care in the emergency department “does not reduce, and may increase, mortality compared with standard care alone.” Although these results are of high significance, they partially contradict previously published studies. We have some concerns about this study.

Leggi
Marzo 2024

Resuscitative Endovascular Balloon Occlusion of the Aorta in Patients With Exsanguinating Hemorrhage

To the Editor We are concerned about the results and interpretation of the UK-REBOA randomized clinical trial. First, this study population may have included cases that were unsuited for resuscitative endovascular balloon occlusion of the aorta (REBOA). The median Abbreviated Injury Scale (AIS) score for the thorax was 4 in both groups, suggesting the presence of severe thoracic trauma. The use of REBOA in patients with thoracic injuries could potentially exacerbate bleeding, thereby raising concerns about the cases in which thoracic trauma was the primary source of severe bleeding.

Leggi
Marzo 2024